Reviewed by Peptide Treatments Medical Advisory Board
Testagen: Research & Evidence
Early-Stage ResearchPublished research, clinical trial data, and evidence grading for Testagen across studied indications.
Back to Testagen overviewResearch Summary
Testagen has zero PubMed-indexed human studies, zero RCTs, and no Western clinical trials. All efficacy claims derive from Russian-language animal studies that have not been independently replicated. FDA-approved testosterone replacement therapies exist with established safety profiles for clinical hypogonadism.
Evidence by Indication (2 indications)
| Indication | Tier | Trials | Summary |
|---|---|---|---|
| Testosterone support | Tier D | 0 | No human trials exist; rodent studies report testosterone increases but remain unverified |
| Male fertility | Tier D | 0 | Animal data suggests spermatogenesis effects but no human translation has been attempted |
Graded using our evidence tier methodology.
Research Gap Score /10
Higher score = larger gap between therapeutic potential and available clinical evidence.